Search results
Can Delcath Systems (DCTH) Climb 277.73% to Reach the Level Wall Street Analysts Expect?
Zacks via Yahoo Finance· 1 month agoThe consensus price target hints at a 277.7% upside potential for Delcath Systems (DCTH). While...
Delcath Systems (DCTH) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 1 month agoInvestors might want to bet on Delcath Systems, Inc. (DCTH), as it has been recently upgraded to a...
Director SALAMON STEVEN A J Acquires 26,882 Shares of Delcath Systems Inc (DCTH)
GuruFocus.com via Yahoo Finance· 1 month agoDelcath Systems Inc (NASDAQ:DCTH), a specialty pharmaceutical and medical device company focused on...
Insiders of Delcath Systems Getting Good Value On Their US$736.5k Investment
Simply Wall St. via Yahoo Finance· 1 month agoDelcath Systems, Inc. (NASDAQ:DCTH) insiders who bought shares over the past year were rewarded...
Retail investors account for 52% of Delcath Systems, Inc.'s (NASDAQ:DCTH) ownership, while...
Simply Wall St. via Yahoo Finance· 3 months agoKey Insights Significant control over Delcath Systems by retail investors implies that the general...
Delcath Systems, Inc. (DCTH) Reports Q2 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoDelcath Systems, Inc. (DCTH) delivered earnings and revenue surprises of -34.09% and 36.49%,...
Delcath Systems Third Quarter 2022 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 year agoDelcath Systems (NASDAQ:DCTH) Third Quarter 2022 ResultsKey Financial Results Revenue: US$906.0k (up...
Delcath Systems Stock Jumps After Data Update From Eye Cancer Trials At ASCO Meeting
Benzinga via Yahoo Finance· 2 years agoDelcath Systems Inc (NASDAQ: DCTH) announced further details regarding presentations relating to its...
Why Delcath Systems Shares Are Jumping Today
Benzinga via Yahoo Finance· 1 year agoDelcath Systems Inc (NASDAQ: DCTH) shares are rising over 23% as FDA accepted its new drug application resubmission for HEPZATO Kit (melphalan...
These 2 “Strong Buy” Penny Stocks Could Soar to $17 (Or Higher), Say Analysts
TipRanks via Yahoo Finance· 8 months agoLet’s take a moment to talk about opportunity, share price, and risk/reward considerations. These...